CompletedNot Applicable

Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer

China213 participantsStarted 2022-09-15

Plain-language summary

The aim of this study is comparing the short-term quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric cancer.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Aged 20-80 years;
✓. Patients had an Eastern Cooperative Oncology Group performance status score of 0 or 1;
✓. Patients had histologically confirmed gastric adenocarcinoma (tumor size\<5cm) at clinical stage I-III with T1-4aN0-2M0 excluding T4b or N3 tumors, according to the of the American Joint Committee on Cancer classification system, eighth edition;
✓. Patients were expected to undergo laparoscopic distal gastrectomy with D2 lymphadenectomy.

Exclusion criteria

✕. Patients had bulky regional lymph nodes (larger than 3 cm at the long diameter) or possible distant metastasis in preoperative evaluation
✕. Patients had history of chemotherapy, radiotherapy, immunotherapy or target therapy;
✕. Patients had any concurrent or previous malignant tumor;
✕. Patients had unstable cardiovascular, respiratory, kidney, or liver disease and poorly controlled hypertension, diabetes, mental disorders; history of upper abdominal surgery (except laparoscopic cholecystectomy).
✕. Patients were histologically proven gastric adenocarcinoma (by preoperative gastrofiberscopy).

What they're measuring

Scores on the physical function and pain symptom scales of EORTC QLQ-C30 questionnaire

Timeframe: 30 days postoperatively

Trial details

NCT IDNCT05541783

SponsorFudan University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-15

View on ClinicalTrials.gov More Gastric Cancer trials